Novel delivery systems in contraception

被引:8
作者
Lähteenmäki, P [1 ]
Jukarainen, H [1 ]
机构
[1] Leiras Oy, Turku 20101, Finland
关键词
D O I
10.1258/0007142001903328
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Contraception has mainly remained the responsibility of women. The sexually active time during the fertile period of life may last over 30 years and, increasingly, it is more than 10 years before the first baby. It is, therefore, natural that convenient long-acting contraceptive methods are becoming more and more appealing. The discovery of poly(dimethylsiloxane) as a carrier, and controlled release polymers for small molecule drugs allowed the development of contraceptive devices releasing steroids for several years. While contraceptive implants and intra-uterine systems are already marketed in many countries, contraceptive vaginal rings are in their late development phase. The key features of these long acting delivery systems are convenience, efficacy, reversibility and positive long-term health effects. Since these methods are based on new concepts, the provider needs to be prepared for extensive counselling.
引用
收藏
页码:739 / 748
页数:10
相关论文
共 27 条
[1]   EVALUATION OF 4 DIFFERENT CONTRACEPTIVE VAGINAL RINGS - STEROID SERUM LEVELS, LUTEAL ACTIVITY, BLEEDING CONTROL AND LIPID PROFILES [J].
ALVAREZSANCHEZ, F ;
BRACHE, V ;
JACKANICZ, T ;
FAUNDES, A .
CONTRACEPTION, 1992, 46 (04) :387-398
[2]   LEVONORGESTREL-RELEASING INTRAUTERINE-DEVICE IN THE TREATMENT OF MENORRHAGIA [J].
ANDERSSON, JK ;
RYBO, G .
BRITISH JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 1990, 97 (08) :690-694
[3]   LEVONORGESTREL-RELEASING AND COPPER-RELEASING (NOVA T) IUDS DURING 5 YEARS OF USE - A RANDOMIZED COMPARATIVE TRIAL [J].
ANDERSSON, K ;
ODLIND, V ;
RYBO, G .
CONTRACEPTION, 1994, 49 (01) :56-72
[4]   OVARIAN-FUNCTION DURING USE OF A LEVONORGESTREL-RELEASING IUD [J].
BARBOSA, I ;
BAKOS, O ;
OLSSON, SE ;
ODLIND, V ;
JOHANSSON, EDB .
CONTRACEPTION, 1990, 42 (01) :51-66
[5]   RECOVERY OF FERTILITY AFTER USE OF THE LEVONORGESTREL 20 MCG/D OR COPPER T-380 AG INTRAUTERINE-DEVICE [J].
BELHADJ, H ;
SIVIN, I ;
DIAZ, S ;
PAVEZ, M ;
TEJADA, AS ;
BRACHE, V ;
ALVAREZ, F ;
SHOUPE, D ;
BREAUX, H ;
MISHELL, DR ;
MCCARTHY, T ;
YO, V .
CONTRACEPTION, 1986, 34 (03) :261-267
[6]  
CHIEN YW, 1992, NOVEL DRUG DELIVERY, P98
[7]   FERTILITY CONTROL IN WOMEN WITH A PROGESTOGEN RELEASED IN MICROQUANTITIES FROM SUBCUTANEOUS CAPSULES [J].
CROXATTO, H ;
DIAZ, S ;
VERA, R ;
ETCHART, M ;
ATRIA, P .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1969, 105 (07) :1135-&
[8]   RETRACTED: The pharmacodynamics and efficacy of Implanon® - An overview of the data (Retracted Article) [J].
Croxatto, HB ;
Mäkäräinen, L .
CONTRACEPTION, 1998, 58 (06) :91S-97S
[9]  
de Nijs H., 1990, US Pat., Patent No. [4,957,119, 4957119]
[10]  
Kirkman RJE, 1999, BRIT J FAM PLAN, V25, P36